Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients.

J Infect · 2021 · PMC7721353 · PMID 33301818

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed that favipiravir was associated with a higher clinical improvement rate than control group, but the difference did not reach statistical significance (odds ratio [OR], 1.54; 95% CI, 0.78–3.04; I 2 = 43%, Fig. 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.